WGU Pathophysiology Final Exam Related

Review WGU Pathophysiology Final Exam related questions and content

A patient is prescribed raloxifene (Evista) for osteoporosis. What is the primary therapeutic action of this medication?

  • A. It stimulates the formation of new bone.
  • B. It decreases bone resorption and increases bone density.
  • C. It increases calcium absorption in the intestines.
  • D. It increases the excretion of calcium through the kidneys.
Correct Answer: B

Rationale: The correct answer is B. Raloxifene works by decreasing bone resorption and increasing bone density, which helps in the prevention and treatment of osteoporosis. Choice A is incorrect as raloxifene does not directly stimulate the formation of new bone. Choice C is incorrect because raloxifene does not primarily affect calcium absorption in the intestines. Choice D is incorrect as raloxifene does not increase the excretion of calcium through the kidneys.